CoChat

Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials

Sarris, Jerome, Mischoulon, David, Schweitzer, Isaac · 2011 · Bipolar Disorders
Cited by 78

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Sarris J, Mischoulon D, Schweitzer I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord 2011: 13: 454–465. © 2011 The Authors. Journal compilation © 2011 John Wiley & Sons A/S. Objective: Studies using augmentation of pharmacotherapies with nutraceuticals in bipolar disorder (BD) have been conducted and preliminary evidence in many cases appears positive. To date, however, no specialized systematic review of this area has been conducted. We present the first systematic review of clinical trials using nutrient‐based nutraceuticals in combination with standard pharmacotherapies to treat BD. A subsequent aim of this report was to discuss posited underlying mechanisms of action. Methods: PubMed, CINAHL, Web of Science, and Cochrane Library databases, and grey literature were searched during mid‐2010 for human clinical trials in English using nutraceuticals such as omega‐3, N‐acetyl cysteine (NAC), inositol, and vitamins and minerals, in combination with pharmacotherapies to treat bipolar mania and bipolar depression. A review of the results including an effect size analysis (Cohen’s d) was subsequently conducted. Results: In treating bipolar depression, positive evidence with large effect sizes were found for NAC (d = 1.04) and a chelated mineral and vitamin formula (d = 1.70). On the outcome of bipolar mania, several nutraceuticals reduced mania with strong clinical effects: a chelated mineral formula (d = 0.83), L‐tryptophan (d = 1.47), magnesium (d = 1.44), folic acid (d = 0.40), and branched‐chain amino acids (d = 1.60). Mixed, but mainly positive, evidence was found for omega‐3 for bipolar depression, while no evidentiary support was found for use in mania. No significant effect on BD outcome scales was found for inositol (possibly due to small samples). Conclusions: BD treatment outcomes may potentially be improved by additional use of certain nutraceuticals with conventional pharmacotherapies. However, caution should be extended in interpreting the large effects of several isolated studies, as they have not yet been replicated in larger trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2011.00945.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 56

  1. Suppes T, 2005, Challenges in the management of bipolar depression, J Clin Psychiatry, 66, 11
  2. 10.1002/jclp.20333 · DOI
  3. 10.1146/annurev.clinpsy.2.022305.095332 · DOI · Paper page
  4. 10.1159/000091771 · DOI · Paper page
  5. 10.1208/ps050325 · DOI · Paper page
  6. 10.1016/j.ogc.2009.10.005 · DOI
  7. 10.1111/j.1753-4887.2009.00180.x · DOI · Paper page
  8. 10.4088/JCP.v62n1204 · DOI · Paper page
  9. 10.1037/0033-2909.133.5.747 · DOI · Paper page
  10. 10.4088/JCP.v62n1203 · DOI · Paper page
  11. 10.1192/bjp.182.3.210 · DOI · Paper page
  12. 10.1007/s00406-007-0711-9 · DOI
  13. 10.1016/j.jpsychires.2008.06.003 · DOI
  14. Tassoni D, 2008, The role of eicosanoids in the brain, Asia Pac J Clin Nutr, 17, 220
  15. 10.1016/j.plefa.2006.07.009 · DOI
  16. 10.2174/1874467210902020207 · doi:10.2174/1874467210902020207 · Paper page
  17. 10.1016/0278-5846(90)90099-3 · DOI
  18. 10.1016/j.phymed.2009.04.001 · DOI
  19. Cohen J, 1988, Statistical Power Analyses for the Behavioral Sciences
  20. 10.4088/JCP.v66n1219b · DOI · Paper page
  21. 10.1038/ejcn.2008.81 · DOI
  22. 10.4088/JCP.v66n0608 · DOI · Paper page
  23. 10.1111/j.1399-5618.2010.00799.x · DOI
  24. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  25. 10.1192/bjp.133.5.429 · DOI · Paper page
  26. 10.1177/0269881106067787 · DOI · Paper page
  27. Hirashima F, 2004, Omega‐3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder, Am J Psychiatry, 161, 1922, 10.1176/ajp.161.10.1922 · DOI · Paper page
  28. 10.1097/MCO.0b013e328336b615 · DOI
  29. 10.1038/sj.mp.4001887 · DOI · Paper page
  30. 10.1016/j.plefa.2006.07.005 · DOI · Paper page
  31. 10.1192/bjp.134.4.382 · DOI · Paper page
  32. 10.1016/0006-3223(85)90026-5 · DOI
  33. Bell CJ, 2005, Acute tryptophan depletion. Part II: clinical effects and implications, Aust N Z J Psychiatry, 39, 565, 10.1080/j.1440-1614.2005.01628.x · DOI · Paper page
  34. 10.1016/j.smrv.2010.04.001 · DOI · Paper page
  35. 10.1034/j.1399-5618.2000.020107.x · DOI · Paper page
  36. 10.1111/j.1399-5618.2006.00303.x · DOI · Paper page
  37. 10.1016/S0165-1781(99)00116-X · DOI
  38. Poleszak E, 2008, Benzodiazepine/GABA(A) receptors are involved in magnesium‐induced anxiolytic‐like behavior in mice, Pharmacol Rep, 60, 483
  39. 10.1016/j.mehy.2006.01.047 · DOI · Paper page
  40. 10.1016/0165-0327(86)90043-1 · DOI
  41. Beck A, 1987, The Beck Depression Inventory
  42. 10.1111/j.1600-0447.2009.01368.x · DOI · Paper page
  43. 10.1176/ajp.2007.164.6.861 · DOI · Paper page
  44. 10.1080/07315724.2009.10719785 · DOI · Paper page
  45. 10.1016/j.plefa.2006.07.003 · DOI
  46. 10.1111/j.1399-5618.2007.00386.x · DOI · Paper page
  47. 10.1016/j.jad.2010.09.004 · DOI · Paper page
  48. 10.1016/S0306-4522(02)00123-9 · DOI · Paper page
  49. 10.1016/j.jacc.2004.03.039 · DOI · Paper page
  50. 10.1176/appi.ajp.2009.09060881 · DOI · Paper page
  51. 10.1016/j.euroneuro.2006.11.006 · DOI · Paper page
  52. 10.1176/appi.ajp.160.5.996 · DOI · Paper page
  53. 10.4088/JCP.v64n0317d · DOI
  54. 10.1016/0006-3223(95)00423-8 · DOI
  55. 10.1016/S0165-1781(99)00107-9 · doi:10.1016/s0165-1781(99)00107-9
  56. 10.1176/ajp.139.9.1162 · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Sarris, J., Mischoulon, D., & Schweitzer, I.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2011-08
Volume
13
Issue
5-6
Pages
454-465
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W1959849744
Cited by
78
References
10
FWCI
0.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. https://app.cochat.ai/papers/10.1111/j.1399-5618.2011.00945.x
The paper
Sarris, J., Mischoulon, D., & Schweitzer, I. (2011). Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2011.00945.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.